In a report released yesterday, Whit Mayo from SVB Securities reiterated a Hold rating on Clover Health Investments (CLOV – Research Report), with a price target of $1.15. The company’s shares opened today at $1.08.
According to TipRanks, Mayo is a 4-star analyst with an average return of 4.2% and a 51.37% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Privia Health Group, Oak Street Health, and Acadia Healthcare.
Clover Health Investments has an analyst consensus of Moderate Sell, with a price target consensus of $1.20.
See Insiders’ Hot Stocks on TipRanks >>
CLOV market cap is currently $521M and has a P/E ratio of -1.53.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.
Read More on CLOV:
- Clover Health Gains on Robust Q4
- Unusually active option classes on open February 28th
- Clover Health reports Q4 revenue $898.8M, consensus $785.38M
- Clover Health Reports Fourth Quarter and Full Year 2022 Financial Results
- Clover Health to Present at Citi’s 2023 Healthcare Conference on March 1, 2023
